Limits...
YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer.

Jefri M, Huang YN, Huang WC, Tai CS, Chen WL - BMC Cancer (2015)

Bottom Line: YKL-40 is a secreted inflammatory protein that its overexpression has been reported to correlate with poor outcome of various malignant diseases, especially in cancer.Furthermore, determined by the PrognoScan database analysis, patients with high expression levels of YKL-40 were found with poor prognosis.In this study,YKL-40 was demonstrated to regulate EMT marker expressions such as Twist, Snail, Slug, N-cadherin, Vimentin, and E-cadherin.

View Article: PubMed Central - PubMed

Affiliation: Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, 1001 University Road, Hsinchu, Taiwan, 300, ROC. malvinjefri@hotmail.com.

ABSTRACT

Background: YKL-40 is a secreted inflammatory protein that its overexpression has been reported to correlate with poor outcome of various malignant diseases, especially in cancer. However, the function of this protein is still unclear.

Methods: The clinical prognosis of non-small cell lung cancers (NSCLC) patients and their clinical YKL-40 expressions were obtained from the Prognoscan database. The expressions of YKL-40 in patient samples were determined by Western Blotting assay. YKL-40 gene knockdown and overexpression were performed on NSCLC cancer cells (CL1-1 and CL1-5). The cells were investigated for their epithelial-mesenchymal transition (EMT) markers gene modulation through Western Blotting and RT-PCR. Further cell metastatic abilities were assessed by transwell migration and invasion assay.

Result: In this study, YKL-40 was observed to be highly expressed in NSCLC specimens. Furthermore, determined by the PrognoScan database analysis, patients with high expression levels of YKL-40 were found with poor prognosis. In the in vitro study, different characteristics of NSCLC cell lines (CL1-1, H23, H838, CL1-5, and H2009) were used as study models, where YKL-40 expression levels were determined to correlate with the phenotypic characteristics of cancer metastasis. In this study,YKL-40 was demonstrated to regulate EMT marker expressions such as Twist, Snail, Slug, N-cadherin, Vimentin, and E-cadherin. The protein's affects in cancer cell migration and invasion were also observed in YKL-40 overexpression or knock down NSCLC cell lines.

Conclusion: All of results from this study suggest that YKL-40 is a major factor in NSCLC metastasis. Thus, YKL-40 may serve as therapeutic targets for NSCLC patients in the future.

No MeSH data available.


Related in: MedlinePlus

a Western Blot analysis comparison of YKL-40 gene expressions in normal lung tissues and non-small cell lung cancer (NSCLC). b YKL-40 immunohistochemistry staining comparison between normal lung tissue and lung tumor tissue (200 x magnification). c YKL-40 expression comparison analysis between normal lung cell and lung adenocarcinoma (Luad) & Lung squamous carcinoma (Lusc), *, P < 0.05, **, P < 0.005 (d) The correlation between YKL40 expression and NSCLC patient prognosis. Comparison of YKL40 expression and patient prognosis was examined using the Prognoscan database
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4537570&req=5

Fig1: a Western Blot analysis comparison of YKL-40 gene expressions in normal lung tissues and non-small cell lung cancer (NSCLC). b YKL-40 immunohistochemistry staining comparison between normal lung tissue and lung tumor tissue (200 x magnification). c YKL-40 expression comparison analysis between normal lung cell and lung adenocarcinoma (Luad) & Lung squamous carcinoma (Lusc), *, P < 0.05, **, P < 0.005 (d) The correlation between YKL40 expression and NSCLC patient prognosis. Comparison of YKL40 expression and patient prognosis was examined using the Prognoscan database

Mentions: Several NSCLC patients were investigated in this study, where consistently higher expressions of YKL-40 were observed in tumor than in non-tumor cells (Fig. 1a). Similar result were found in our immunohistochemistry staining analysis that compared the YKL-40 expression of normal lung cells and lung tumor cells (Fig. 1b). These results were further confirmed through TCGA analysis, by comparing YKL-40 expression between normal and lung adenocarcinoma as well as lung squamous carcinoma populations. The analysis determined that YKL-40 expressions were highly upregulated among lung carcinoma populations (Fig. 1c). Finally, we investigated the correlation of YKL-40 expression and NSCLC patient prognosis using the PrognoScan database (http://www.prognoscan.org/). As shown in Fig. 1d, high expression of YKL-40 was correlated with poor NSCLC patient prognosis.Fig. 1


YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer.

Jefri M, Huang YN, Huang WC, Tai CS, Chen WL - BMC Cancer (2015)

a Western Blot analysis comparison of YKL-40 gene expressions in normal lung tissues and non-small cell lung cancer (NSCLC). b YKL-40 immunohistochemistry staining comparison between normal lung tissue and lung tumor tissue (200 x magnification). c YKL-40 expression comparison analysis between normal lung cell and lung adenocarcinoma (Luad) & Lung squamous carcinoma (Lusc), *, P < 0.05, **, P < 0.005 (d) The correlation between YKL40 expression and NSCLC patient prognosis. Comparison of YKL40 expression and patient prognosis was examined using the Prognoscan database
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4537570&req=5

Fig1: a Western Blot analysis comparison of YKL-40 gene expressions in normal lung tissues and non-small cell lung cancer (NSCLC). b YKL-40 immunohistochemistry staining comparison between normal lung tissue and lung tumor tissue (200 x magnification). c YKL-40 expression comparison analysis between normal lung cell and lung adenocarcinoma (Luad) & Lung squamous carcinoma (Lusc), *, P < 0.05, **, P < 0.005 (d) The correlation between YKL40 expression and NSCLC patient prognosis. Comparison of YKL40 expression and patient prognosis was examined using the Prognoscan database
Mentions: Several NSCLC patients were investigated in this study, where consistently higher expressions of YKL-40 were observed in tumor than in non-tumor cells (Fig. 1a). Similar result were found in our immunohistochemistry staining analysis that compared the YKL-40 expression of normal lung cells and lung tumor cells (Fig. 1b). These results were further confirmed through TCGA analysis, by comparing YKL-40 expression between normal and lung adenocarcinoma as well as lung squamous carcinoma populations. The analysis determined that YKL-40 expressions were highly upregulated among lung carcinoma populations (Fig. 1c). Finally, we investigated the correlation of YKL-40 expression and NSCLC patient prognosis using the PrognoScan database (http://www.prognoscan.org/). As shown in Fig. 1d, high expression of YKL-40 was correlated with poor NSCLC patient prognosis.Fig. 1

Bottom Line: YKL-40 is a secreted inflammatory protein that its overexpression has been reported to correlate with poor outcome of various malignant diseases, especially in cancer.Furthermore, determined by the PrognoScan database analysis, patients with high expression levels of YKL-40 were found with poor prognosis.In this study,YKL-40 was demonstrated to regulate EMT marker expressions such as Twist, Snail, Slug, N-cadherin, Vimentin, and E-cadherin.

View Article: PubMed Central - PubMed

Affiliation: Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, 1001 University Road, Hsinchu, Taiwan, 300, ROC. malvinjefri@hotmail.com.

ABSTRACT

Background: YKL-40 is a secreted inflammatory protein that its overexpression has been reported to correlate with poor outcome of various malignant diseases, especially in cancer. However, the function of this protein is still unclear.

Methods: The clinical prognosis of non-small cell lung cancers (NSCLC) patients and their clinical YKL-40 expressions were obtained from the Prognoscan database. The expressions of YKL-40 in patient samples were determined by Western Blotting assay. YKL-40 gene knockdown and overexpression were performed on NSCLC cancer cells (CL1-1 and CL1-5). The cells were investigated for their epithelial-mesenchymal transition (EMT) markers gene modulation through Western Blotting and RT-PCR. Further cell metastatic abilities were assessed by transwell migration and invasion assay.

Result: In this study, YKL-40 was observed to be highly expressed in NSCLC specimens. Furthermore, determined by the PrognoScan database analysis, patients with high expression levels of YKL-40 were found with poor prognosis. In the in vitro study, different characteristics of NSCLC cell lines (CL1-1, H23, H838, CL1-5, and H2009) were used as study models, where YKL-40 expression levels were determined to correlate with the phenotypic characteristics of cancer metastasis. In this study,YKL-40 was demonstrated to regulate EMT marker expressions such as Twist, Snail, Slug, N-cadherin, Vimentin, and E-cadherin. The protein's affects in cancer cell migration and invasion were also observed in YKL-40 overexpression or knock down NSCLC cell lines.

Conclusion: All of results from this study suggest that YKL-40 is a major factor in NSCLC metastasis. Thus, YKL-40 may serve as therapeutic targets for NSCLC patients in the future.

No MeSH data available.


Related in: MedlinePlus